The Effects of Bortezomib on Bone Disease in Patients With Multiple Myeloma

CANCER

WILEY

1. Celgene
2. Janssen
3. Association for Training, Education and Research in Hematology, Immunology and Transplantation (ATERHIT)
4. (Hospital Clinical Research Program, PHRC) from the French National Cancer Institute (INCa)
5. Janssen-Cilag
6. Amgen
7. Novartis